Jaguar Health says Series R preferred converted into 13,345,986 common shares
Jaguar Health disclosed that on November 2, 2026, each outstanding share of its Series R Convertible Preferred Stock automatically converted into five shares of common stock. Immediately after the conversion, 13,345,986 common shares were issued and outstanding, and holders of eligible warrants may receive up to 69,823 more common shares upon exercise. The filing is administrative in nature and does not report revenue, profit, or guidance.
Key points
- Series R Preferred Stock converted into common stock on November 2, 2026, at five common shares per preferred share
- 13,345,986 shares of common stock outstanding immediately after the conversion
- Eligible warrants may be exercised for up to 69,823 common shares, including the Series O preferred dividend and Series R dividend shares
- Special dividend of Series O preferred stock was paid on October 15, 2026, to holders of record on October 13, 2026
The filing
Written by AI on Nov 9, 2026, 8:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 03, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.